期刊文献+

儿童原发免疫性血小板减少症IL-37、VEGFA、TGF-β1的表达及其与T细胞的相关性研究 被引量:1

Expression of interleukin-37,vascular endothelial growth factor A,and transforming growth factor-β1 and their correlation with T cells in children with primary immune thrombocytopenia
在线阅读 下载PDF
导出
摘要 目的探讨白细胞介素-37(interleukin-37,IL-37)、血管内皮生长因子A(vascular endothelial growth factor,VEGFA)、转化生长因子-β1(transforming growth factor-β1,TGF-β1)在儿童原发免疫性血小板减少症(primary immune thrombocytopenia,ITP)患儿中的表达及其与T细胞的相关性。方法回顾性选取河北省邯郸市中心医院于2020年1月—2022年4月收治的45例ITP患儿为ITP组,选取30例同期健康体检儿童为健康对照组。测定并比较ITP组患儿治疗前后及健康对照组儿童的IL-37、VEGFA、TGF-β1 mRNA水平,以及调节性T细胞(regulatoryT cell,Treg)和辅助性T细胞17(helper T cell 17,Th17)的水平差异,分析IL-37、VEGFA、TGF-β1 mRNA水平与Treg、Th17及Treg/Th17的相关性。结果ITP组患儿治疗前后IL-37 mRNA及Th17水平高于健康对照组,VEGFA、TGF-β1 mRNA及Treg、Treg/Th17水平低于健康对照组(P<0.05);且与治疗前比较,治疗后ITP组患儿IL-37 mRNA、Th17水平下降,VEGFA、TGF-β1 mRNA及Treg、Treg/Th17水平上升(P<0.05)。相关性分析结果显示,ITP组患儿治疗前后IL-37 mRNA、TGF-β1 mRNA水平与Treg、Treg/Th17呈显著负相关(P<0.05),与Th17呈显著正相关(P<0.05);治疗前后VEGFA mRNA水平与Treg、Treg/Th17呈显著正相关(P<0.05),与Th17呈显著负相关(P<0.05)。结论IL-37、VEGFA、TGF-β1在儿童ITP中存在异常表达,且与Treg/Th17比例失衡有明显关系,推测IL-37、VEGFA、TGF-β1等细胞因子可能参与疾病的发生与发展,或可成为治疗儿童ITP的重要潜在靶点。 Objective To investigate the expression of interleukin-37(IL-37),vascular endothelial growth factor A(VEGFA),and transforming growth factor-β1(TGF-β1)in children with primary immune thrombocytopenia(ITP)and their correlation with T cells.Methods A retrospective analysis was conducted on 45 children with ITP(ITP group)who were admitted to Handan Central Hospital from January 2020 to April 2022,and 30 healthy children who underwent physical examination during the same period were included as the healthy control group.The mRNA expression levels of IL-37,VEGFA,and TGF-β1 and the levels of regulatory T cells(Treg)and helper T cells 17(Th17)were measured before and after treatment,and the correlation between the mRNA expression levels of IL-37,VEGFA,and TGF-β1 and the levels of Treg,Th17,and Treg/Th17 ratio were analyzed.Results Compared with the healthy control group,the ITP group had a significantly higher mRNA expression level of IL-37 and a significantly higher level of Th17 before and after treatment,as well as significantly lower mRNA expression levels of VEGFA and TGF-β1 and significantly lower levels of Treg and Treg/Th17 ratio(P<0.05).After treatment,the ITP group had significant reductions in the mRNA expression level of IL-37 and the level of Th17 and significant increases in the mRNA expression levels of VEGFA and TGF-β1 and the levels of Treg and Treg/Th17 ratio(P<0.05).Correlation analysis showed that in the ITP group,the mRNA expression levels of IL-37 and TGF-β1 were negatively correlated with the levels of Treg and Treg/Th17 ratio(P<0.05)and were positively correlated with the level of Th17(P<0.05)before and after treatment;the mRNA expression level of VEGFA was positively correlated with the levels of Treg and Treg/Th17 ratio(P<0.05)and was negatively correlated with the Th17 level(P<0.05)before and after treatment.Conclusions Abnormal expression levels of IL-37,VEGFA,and TGF-β1 may be observed in children with ITP,which is significantly associated with the imbalance of Treg/Th17 ratio.It is speculated that the cytokines such as IL-37,VEGFA,and TGF-β1 may be involved in the development and progression of ITP or may become important potential targets for the treatment of children with ITP.
作者 童琳琳 王立华 方芳 许彬 郑素华 TONG Lin-Lin;WANG Li-Hua;FANG Fang;XU Bin;ZHENG Su-Hua(Department of Pediatrics,Handan Central Hospital,Handan,Hebei 056001,China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2023年第11期1131-1136,共6页 Chinese Journal of Contemporary Pediatrics
基金 河北省卫生厅科研基金项目(20191863)。
关键词 原发免疫性血小板减少症 白细胞介素-37 血管内皮生长因子A 转化生长因子-β1 T细胞 儿童 Primary immune thrombocytopenia Interleukin-37 Vascular endothelial growth factor A Transforming growth factor-β1 T cell Child
  • 相关文献

参考文献13

二级参考文献95

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 2赵湜,王红祥,李菁媛,毛红,邹萍.调节性T细胞在慢性特发性血小板减少性紫癜中的作用[J].中华血液学杂志,2006,27(3):203-205. 被引量:17
  • 3Provan D, Stasi R, Newland AC, et al.International consensus re- port on the investigation and management of primary immune thrombocytopenia[J ].Blood, 2010,115(2) : 168-186.
  • 4Neunert C, Lira W, Crowther M, et al.American Society of Hema- tology. The American Society of Hematology 2011 evi- dence-based practice guideline for immune thrombocytope- nia[J ].Blood,2011,117(16) :4190-4207.
  • 5Medeiros D, Buchanan GR.Idiopathic thrombocytopenic purpu- ra : beyond consensus [ J ].Curr Opin Pediatr, 2000,12: 4-9.
  • 6Rodeghiero F, Stasi R, Gernsheimer T, et al.Standardization of terminology, definitions and outcome criteria in immune throm- bocytopenic purpura of adults and children:report from an inter- national working group[J].Blood, 2009,113 ( 11 ) : 2386 - 2393.
  • 7Abshire T.Childhood ITP: can we venture below 20000? [J]. Blood,2008,112(10) :3918-3919.
  • 8Grainger JD, Rees JL, Reeves M, et al. Changing trends in the UK management of childhood ITP[J].Arch Dis Child, 2012,97 (1):8-11.
  • 9Page KL, Psaila B, Provan D, et al.The immune thrombocytope- nic purpura(ITP)bleeding score: assessment of bleeding in pa- tients with ITP[J].Br J Haematol, 2007,138 : 245 -248.
  • 10Buchanan GR, Adix L.Grading of hemorrhage in children with idiopathic thrombocytopenic purpura [J].J Pediatr, 2002, 141 : 683-688.

共引文献118

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部